Get started
Author

Mymoona Alzouebi

Observed names: Dr. Mymoona Alzouebi, M Alzouebi, M. Alzouebi
OpenAlex ID: A5067871333
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
2015 · Nicholas D James, Matthew R Sydes, et al. · The Lancet · 1,979
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
2023 · Gerhardt Attard, Laura Murphy, et al. · The Lancet Oncology · 118
PDF
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
2024 · Chris C Parker, Noel W Clarke, et al. · The Lancet · 53
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
2018 · Beth S. Woods, Eleftherios Sideris, et al. · European Urology Oncology · 27
PDF
Acute polyradiculoneuropathy with renal failure: mind the anion gap
2008 · M Alzouebi, P G Sarrigiannis, et al. · Journal of Neurology Neurosurgery & Psychiatry · 8
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Use of systemic therapy in the treatment of choroidal metastases from breast cancer
2014 · Mymoona Alzouebi, Sundareswaran Ramakrishnan, et al. · BMJ Case Reports · 4
PDF
Paediatric chest radiographs
2005 · Mymoona Alzouebi, Iwan Roberts · BMJ · 4
Overcoming Logistical Delays and Resource Constraints: Achieving Complete Response in High-Risk Medulloblastoma with Delayed Metastatic Progression at a Newly Established Secondary Cancer Center
2026 · Mymoona Alzouebi, Dahlawi Ismail Al, et al. · SVOA Medical Research
PDF
The Role of Radiation Therapists in Establishing a New Radiotherapy Centre Abdul Latif Aljaber Oncology Centre, King Fahad Hospital Al- Ahsa, Ministry of Health, Kingdom of Saudi Arabia
2026 · AbdulMajeed Alanazi, Jumana Alkhalifah, et al. · SVOA Medical Research
PDF
Practicing Oncology in the UK National Health Service Versus Kingdom of Saudi Arabia Ministry of Health Hospitals: A Personal Reflection
2025 · Mymoona Alzouebi · SVOA Medical Research
PDF
Establishing a New Radiotherapy Centre in Al-Ahsa, Saudi Arabia: Challenges and Successes
2025 · Dr. Mymoona Alzouebi, Dr. Salem Ben Abdulrahman, et al. · SVOA Medical Research
PDF
Revisit the indication and feedback of palliative radiotherapy in pain control
2022 · Ereny Saad, Mymoona Alzouebi · Clinical Oncology
Non-surgical treatment of breast cancer
2016 · Mymoona Alzouebi, Matthew Q. F. Hatton
Radiotherapy principles
2015 · Martin Robinson, Mymoona Alzouebi · Jaypee Brothers Medical Publishers (P) Ltd. eBooks
158 Thoracic radiotherapy planning: Where's the heart?
2014 · R. Crossley, N. Foley, et al. · Lung Cancer
153 FDG-PET parameters as predictors for outcome in non-small cell lung cancer (NSCLC) treated with stereotactic ablative radiotherapy (SABR) at the St James's Institute of Oncology
2014 · M. Alzouebi, M. Subesinghe, et al. · Lung Cancer
36 Palliative chemotherapy with carboplatin and oral vinorelbine in advanced/metastatic non-small cell lung cancer – North Trent Cancer Network experience
2013 · M. Alzouebi, R. Saman, et al. · Lung Cancer
Are outcomes of adjuvant vaginal vault brachytherapy in endometrial cancer related to the way it is delivered?
2011 · M. Alzouebi, S.D. Pledge, et al. · Journal of Radiotherapy in Practice
Audit of adjuvant vinorelbine and cisplatin for patients with resected NSCLC
2010 · M. Alzouebi, P. Fisher, et al. · Lung Cancer
Works count: 20
Citation count: 2,195
H-index: 5
I10-index: 4
Year
Topic
Type